Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...

Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...

A new study shows how cultural differences drive plant-based meat consumption in the UK and Singapore, and how brands can ...

Discover the Top 12 American Skincare Brands [Update 2025] dominating the beauty scene with innovative, effective products ...

When health challenges disrupted their lives, sisters Veda and Sudha channelled their science backgrounds to create Earthful, ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We have a responsibility to ensure that our discoveries are used in the public interest. That isn’t always easy.

These natural coatings enhance the performance of plastics while reducing their environmental footprint, offering a practical ...